Back to Journals » Drug Design, Development and Therapy » Volume 9
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,722 | Dovepress* | 10,083+ | 1,727 | 11,810 | |
PubMed Central* | 1,639 | 444 | 2,083 | ||
Totals | 11,722 | 2,171 | 13,893 | ||
*Since 8 June 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar